Document is current
Any future updates will be listed below
-
Authors
Wada, Iori
Nakao, Shintaro https://orcid.org/0000-0003-4200-0052
Shiose, Satomi
Kaizu, Yoshihiro
Yamaguchi, Muneo
Ishikawa, Keijiro
Kiyohara, Kohei
Ishibashi, Tatsuro
Sonoda, Koh-Hei
-
Funding
Funding for this research was provided by:
JSPS KAKENHI (20K09829)
Charitable Trust Fund for Ophthalmic Research in Commemoration of Santen Pharmaceutical's Founder
Novartis Pharma Research Grants
Alcon Pharma Research Grants
The Foundation for The Advancement of Clinical Medicine,
- License Information
-
More Information
Article History
Received: 27 November 2024
Accepted: 14 April 2025
First Online: 12 June 2025
Declarations
:
: I. Wada, None; S. Nakao, Consulting fees (Kowa), Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events, Support for attending meetings and/or travel (Novartis, Bayer, Canon, Santen, Kowa, Senju, Ono, MSD); S. Shiose, None; Y. Kaizu, None; M. Yamaguchi, None; K. Ishikawa, None; K. Kiyohara, None; T. Ishibashi, Consulting fees (Kowa), Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events, Support for attending meetings and/or travel (Novartis, Bayer, Santen, Senju, Otsuka, Bausch and Lomb, Rohto); K. Sonoda, Consulting fees (Kowa, JT, AbbVie), Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events, Support for attending meetings and/or travel (Novartis, Bayer, Canon, Santen, Kowa, Senju, Ono, MSD, HOYA, Wakamoto, AMO, Alcon, Otsuka, AbbVie, Eisai, Nidek, Topcon, Novo Nordisk, Mitsubishi Tanabe, Sumitomo Dainippon, Astellas).
